Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$27,000.00
Sex-Based Functional Network Differences in Major Depressive Disorder
FY 2024-25
Summary
Major Depressive Disorder (MDD) is the leading cause of disability worldwide, affecting approximately 5% of adults. Biological sex is a major risk factor for MDD, with twice the prevalence in women than men. Research identifies notable sex-based differences in symptoms and brain function, but little is known about how these factors influence therapy outcomes. Drug therapy is one of the most common treatments worldwide, known to normalize brain network abnormalities, with women displaying higher treatment success than men. This project examines sex differences in how brain functional connectivity predicts drug treatment success, as well as associated changes with therapy. The study focuses on initial differences in resting-state functional networks (the default mode (DMN), cognitive control (CCN), and salience (SN) networks), their predictive features of treatment response, and their changes associated with effective treatment. Using a large multisite dataset from the Canadian Biomarker Integration Network in Depression (CAN-BIND), the study includes 148 MDD patients (equal sex ratio, aged 18-60) treated with Escitalopram for 16 weeks, with Aripiprazole added if symptom improved less than 50% at week 8. Resting state functional magnetic resonance imaging fMRI data were collected at baseline, 2, and 8 weeks. Multivariate partial least squares analysis (PLS) will explore sex-specific connectivity within and between DMN, SN, and CCN and relate connectivity patterns to treatment outcomes. This work will advance the understanding of MDD causes and progression by identifying sex-specific brain features associated with treatment success. Findings may inform personalized, sex-sensitive therapeutic strategies, improving treatment outcomes for a prevalent and disabling condition.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530348
Name
Mukhametzyanova Anastasia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex-Based Functional Network Differences in Major Depressive Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Depression; Depression Treatment; Fmri; Functional Magnetic Resonance Imagining; Functional Networks; Major Depressive Disorder; Mdd; Pharmacotherapy; Sex; Sex-Based Differences
Abstract
Major Depressive Disorder (MDD) is the leading cause of disability worldwide, affecting approximately 5% of adults. Biological sex is a major risk factor for MDD, with twice the prevalence in women than men. Research identifies notable sex-based differences in symptoms and brain function, but little is known about how these factors influence therapy outcomes. Drug therapy is one of the most common treatments worldwide, known to normalize brain network abnormalities, with women displaying higher treatment success than men. This project examines sex differences in how brain functional connectivity predicts drug treatment success, as well as associated changes with therapy. The study focuses on initial differences in resting-state functional networks (the default mode (DMN), cognitive control (CCN), and salience (SN) networks), their predictive features of treatment response, and their changes associated with effective treatment. Using a large multisite dataset from the Canadian Biomarker Integration Network in Depression (CAN-BIND), the study includes 148 MDD patients (equal sex ratio, aged 18-60) treated with Escitalopram for 16 weeks, with Aripiprazole added if symptom improved less than 50% at week 8. Resting state functional magnetic resonance imaging fMRI data were collected at baseline, 2, and 8 weeks. Multivariate partial least squares analysis (PLS) will explore sex-specific connectivity within and between DMN, SN, and CCN and relate connectivity patterns to treatment outcomes. This work will advance the understanding of MDD causes and progression by identifying sex-specific brain features associated with treatment success. Findings may inform personalized, sex-sensitive therapeutic strategies, improving treatment outcomes for a prevalent and disabling condition.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mukhametzyanova, Anastasia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~